Literature DB >> 18851914

Tetrakis-azaaromatic quaternary ammonium salts: novel subtype-selective antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.

Zhenfa Zhang1, Guangrong Zheng, Marharyta Pivavarchyk, A Gabriela Deaciuc, Linda P Dwoskin, Peter A Crooks.   

Abstract

A series of tetrakis-azaaromatic quaternary ammonium salts was synthesized to identify compounds with higher affinity and selectivity as antagonists at neuronal nicotinic receptor subtypes (nAChR) that mediate nicotine-evoked DA release. A high hit rate was achieved in identifying potent analogs that inhibit these nAChRs. Three tetrakis analogs, 11j, 11f, and 11g, were identified as potent (IC(50)=3, 28 and 56nM, respectively) antagonists at these receptors. These compounds represent a novel structural class of nicotinic receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18851914      PMCID: PMC3437627          DOI: 10.1016/j.bmcl.2008.09.084

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

Review 1.  Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release.

Authors:  Charles W Luetje
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

2.  Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.

Authors:  Peter A Crooks; Joshua T Ayers; Rui Xu; Sangeetha P Sumithran; Vladimir P Grinevich; Lincoln H Wilkins; A Gabriela Deaciuc; David D Allen; Linda P Dwoskin
Journal:  Bioorg Med Chem Lett       Date:  2004-04-19       Impact factor: 2.823

3.  The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.

Authors:  W A Corrigall; K B Franklin; K M Coen; P B Clarke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 4.  Synaptic plasticity and nicotine addiction.

Authors:  J A Dani; D Ji; F M Zhou
Journal:  Neuron       Date:  2001-08-16       Impact factor: 17.173

5.  N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slices.

Authors:  Lincoln H Wilkins; Aaron Haubner; Joshua T Ayers; Peter A Crooks; Linda P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

6.  Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.

Authors:  J E Rose; F M Behm; E C Westman; E D Levin; R M Stein; G V Ripka
Journal:  Clin Pharmacol Ther       Date:  1994-07       Impact factor: 6.875

7.  Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.

Authors:  Linda P Dwoskin; Sangeetha P Sumithran; Jun Zhu; A Gabriela Deaciuc; Joshua T Ayers; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2004-04-19       Impact factor: 2.823

8.  N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.

Authors:  Lincoln H Wilkins; Vladimir P Grinevich; Joshua T Ayers; Peter A Crooks; Linda P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

9.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Authors:  Outi Salminen; Karen L Murphy; J Michael McIntosh; John Drago; Michael J Marks; Allan C Collins; Sharon R Grady
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

10.  Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum.

Authors:  S Grady; M J Marks; S Wonnacott; A C Collins
Journal:  J Neurochem       Date:  1992-09       Impact factor: 5.372

View more
  8 in total

1.  Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats.

Authors:  Elzbieta P Wala; Peter A Crooks; J Michael McIntosh; Joseph R Holtman
Journal:  Anesth Analg       Date:  2012-05-18       Impact factor: 5.108

2.  The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic.

Authors:  Joseph R Holtman; Linda P Dwoskin; Cheryl Dowell; Elzbieta P Wala; Zhenfa Zhang; Peter A Crooks; J Michael McIntosh
Journal:  Eur J Pharmacol       Date:  2011-09-17       Impact factor: 4.432

Review 3.  Nicotinic receptor antagonists as treatments for nicotine abuse.

Authors:  Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Adv Pharmacol       Date:  2014

4.  Novel bis-, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.

Authors:  Zhenfa Zhang; Guangrong Zheng; Marharyta Pivavarchyk; A Gabriela Deaciuc; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2010-11-24       Impact factor: 2.823

5.  Discovery of non-peptide, small molecule antagonists of α9α10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain.

Authors:  Guangrong Zheng; Zhenfa Zhang; Cheryl Dowell; Elzbieta Wala; Linda P Dwoskin; Joseph R Holtman; J Michael McIntosh; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2011-02-23       Impact factor: 2.823

6.  Scientific overview: 2013 BBC plenary symposium on tobacco addiction.

Authors:  M De Biasi; I McLaughlin; E E Perez; P A Crooks; L P Dwoskin; M T Bardo; P R Pentel; D Hatsukami
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

7.  Novel bis-2,2,6,6-tetramethylpiperidine (bis-TMP) and bis-mecamylamine antagonists at neuronal nicotinic receptors mediating nicotine-evoked dopamine release.

Authors:  Zhenfa Zhang; Marharyta Pivavarchyk; Karunai Leela Subramanian; A Gabriela Deaciuc; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2010-01-04       Impact factor: 2.823

8.  Characterizing the Access of Cholinergic Antagonists to Efferent Synapses in the Inner Ear.

Authors:  Choongheon Lee; Anjali K Sinha; Kenneth Henry; Anqi W Walbaum; Peter A Crooks; Joseph C Holt
Journal:  Front Neurosci       Date:  2021-12-14       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.